Back
Pyxis Oncology Stock Price Chart

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Sell
43
PYXS
Pyxis Oncology
Last Price:
$1.11
Seasonality Move:
-14.84%
7 Day Trial
ALL ACCESS PASS
$
7

Your Summer Trading Shortcut
Try it free today.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PYXS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Pyxis Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.18 | Buy |
20-day SMA: | 1.22 | Sell |
50-day SMA: | 1.18 | Buy |
200-day SMA: | 1.93 | Sell |
8-day EMA: | 1.16 | Buy |
20-day EMA: | 1.19 | Buy |
50-day EMA: | 1.19 | Buy |
200-day EMA: | 1.78 | Sell |
Pyxis Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.73 | Buy |
Chaikin Money Flow: | 521860 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.15 - 1.29) | Sell |
Bollinger Bands (100): | (1.02 - 1.28) | Buy |
Pyxis Oncology Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pyxis Oncology Stock
Is Pyxis Oncology Stock a Buy?
-
Pyxis Oncology share price is 1.20 while PYXS 8-day simple moving average is 1.18, which is a Buy signal.
-
The stock price of PYXS is 1.20 while Pyxis Oncology 20-day SMA is 1.22, which makes it a Sell.
-
Pyxis Oncology 50-day simple moving average is 1.18 while PYXS share price is 1.20, making it a Buy technically.
-
PYXS stock price is 1.20 and Pyxis Oncology 200-day simple moving average is 1.93, creating a Sell signal.
PYXS Technical Analysis vs Fundamental Analysis
Sell
43
Pyxis Oncology (PYXS)
is a Sell
Is Pyxis Oncology a Buy or a Sell?
-
Pyxis Oncology stock is rated a SellThe current Pyxis Oncology [PYXS] share price is $1.20. The Score for PYXS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Pyxis Oncology Stock Info
Market Cap:
74.3M
Price in USD:
1.20
Share Volume:
591.6K
Pyxis Oncology 52-Week Range
52-Week High:
5.39
52-Week Low:
0.83
Sell
43
Pyxis Oncology (PYXS)
is a Sell
Pyxis Oncology Share Price Forecast
-
What is the Pyxis Oncology stock price today?The Pyxis Oncology stock price is 1.20 USD today.
-
Will PYXS stock go up or go down?Pyxis Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Pyxis Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pyxis Oncology is overvalued.
Is Pyxis Oncology Stock a Buy?
-
Pyxis Oncology share price is 1.20 while PYXS 8-day exponential moving average is 1.16, which is a Buy signal.
-
The stock price of PYXS is 1.20 while Pyxis Oncology 20-day EMA is 1.19, which makes it a Buy.
-
Pyxis Oncology 50-day exponential moving average is 1.19 while PYXS share price is 1.20, making it a Buy technically.
-
PYXS stock price is 1.20 and Pyxis Oncology 200-day simple moving average is 1.78, creating a Sell signal.
Fundamental Analysis of Pyxis Oncology
Is Pyxis Oncology a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.31 per share, and an increase next year of $0.18 per share.
Technical Analysis of Pyxis Oncology
Should I short Pyxis Oncology stock?
-
PYXS Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Pyxis Oncology is a Sell
-
Pyxis Oncology Relative Strength Index (RSI) is 50.73, which suggest Pyxis Oncology is overbought
-
The Bollinger Bands (25) for Pyxis Oncology is (1.15 - 1.29), which suggest Pyxis Oncology is a Buy
-
The Bollinger Bands (100) for Pyxis Oncology is (1.02 - 1.28), which suggest Pyxis Oncology is a Buy
* Pyxis Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.